343 related articles for article (PubMed ID: 22910441)
1. Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.
Johnson JA; Burkley BM; Langaee TY; Clare-Salzler MJ; Klein TE; Altman RB
Clin Pharmacol Ther; 2012 Oct; 92(4):437-9. PubMed ID: 22910441
[TBL] [Abstract][Full Text] [Related]
2. Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics.
Johnson JA; Elsey AR; Clare-Salzler MJ; Nessl D; Conlon M; Nelson DR
Pharmacogenomics; 2013 May; 14(7):723-6. PubMed ID: 23651020
[TBL] [Abstract][Full Text] [Related]
3. Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years.
Borobia AM; Dapia I; Tong HY; Arias P; Muñoz M; Tenorio J; Hernández R; García García I; Gordo G; Ramírez E; Frías J; Lapunzina P; Carcas AJ
Clin Transl Sci; 2018 Mar; 11(2):189-199. PubMed ID: 29193749
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic content of commercial genome-wide genotyping arrays.
Lemieux Perreault LP; Zaïd N; Cameron M; Mongrain I; Dubé MP
Pharmacogenomics; 2018 Oct; 19(15):1159-1167. PubMed ID: 30272537
[TBL] [Abstract][Full Text] [Related]
5. Future prospects for pharmacogenetics in the quest for personalized medicine.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2012 Dec; 50(12):13-6. PubMed ID: 23457712
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics knowledge for personalized medicine.
Whirl-Carrillo M; McDonagh EM; Hebert JM; Gong L; Sangkuhl K; Thorn CF; Altman RB; Klein TE
Clin Pharmacol Ther; 2012 Oct; 92(4):414-7. PubMed ID: 22992668
[TBL] [Abstract][Full Text] [Related]
7. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
[TBL] [Abstract][Full Text] [Related]
8. Institutional profile: University of Florida Health Personalized Medicine Program.
Cavallari LH; Weitzel KW; Elsey AR; Liu X; Mosley SA; Smith DM; Staley BJ; Winterstein AG; Mathews CA; Franchi F; Rollini F; Angiolillo DJ; Starostik P; Clare-Salzler MJ; Nelson DR; Johnson JA
Pharmacogenomics; 2017 Apr; 18(5):421-426. PubMed ID: 28346068
[TBL] [Abstract][Full Text] [Related]
9. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
[TBL] [Abstract][Full Text] [Related]
10. Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?
Johnson JA; Weitzel KW
Clin Pharmacol Ther; 2016 Feb; 99(2):154-6. PubMed ID: 26440500
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery.
Radhakrishnan A; Kuppusamy G; Ponnusankar S; Shanmukhan NK
Pharmacogenomics J; 2020 Feb; 20(1):1-18. PubMed ID: 31819163
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics Clinical Annotation Tool (PharmCAT).
Sangkuhl K; Whirl-Carrillo M; Whaley RM; Woon M; Lavertu A; Altman RB; Carter L; Verma A; Ritchie MD; Klein TE
Clin Pharmacol Ther; 2020 Jan; 107(1):203-210. PubMed ID: 31306493
[TBL] [Abstract][Full Text] [Related]
13. Rapid and cost-effective SNP detection method: application of SmartAmp2 to pharmacogenomics research.
Mitani Y; Lezhava A; Sakurai A; Horikawa A; Nagakura M; Hayashizaki Y; Ishikawa T
Pharmacogenomics; 2009 Jul; 10(7):1187-97. PubMed ID: 19604094
[TBL] [Abstract][Full Text] [Related]
14. Personalizing medicine with clinical pharmacogenetics.
Scott SA
Genet Med; 2011 Dec; 13(12):987-95. PubMed ID: 22095251
[TBL] [Abstract][Full Text] [Related]
15. Personalized medicine: potential, barriers and contemporary issues.
Sorich MJ; McKinnon RA
Curr Drug Metab; 2012 Sep; 13(7):1000-6. PubMed ID: 22591350
[TBL] [Abstract][Full Text] [Related]
16. PARC report: health outcomes and value of personalized medicine interventions: impact on patient care.
Mitropoulou C; Litinski V; Kabakchiev B; Rogers S; P Patrinos G
Pharmacogenomics; 2020 Jul; 21(11):797-807. PubMed ID: 32635813
[TBL] [Abstract][Full Text] [Related]
17. Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.
Shuldiner AR; Palmer K; Pakyz RE; Alestock TD; Maloney KA; O'Neill C; Bhatty S; Schub J; Overby CL; Horenstein RB; Pollin TI; Kelemen MD; Beitelshees AL; Robinson SW; Blitzer MG; McArdle PF; Brown L; Jeng LJ; Zhao RY; Ambulos N; Vesely MR
Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):76-84. PubMed ID: 24616408
[TBL] [Abstract][Full Text] [Related]
18. Editorial: SNPs of drug metabolic enzymes and personalized medicine Part II.
Wei DQ; Chen Q
Curr Drug Metab; 2012 Sep; 13(7):951. PubMed ID: 22475268
[No Abstract] [Full Text] [Related]
19. Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions.
Klein ME; Parvez MM; Shin JG
J Pharm Sci; 2017 Sep; 106(9):2368-2379. PubMed ID: 28619604
[TBL] [Abstract][Full Text] [Related]
20. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Dunnenberger HM; Crews KR; Hoffman JM; Caudle KE; Broeckel U; Howard SC; Hunkler RJ; Klein TE; Evans WE; Relling MV
Annu Rev Pharmacol Toxicol; 2015; 55():89-106. PubMed ID: 25292429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
